1. Home
  2. STVN vs RHP Comparison

STVN vs RHP Comparison

Compare STVN & RHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • RHP
  • Stock Information
  • Founded
  • STVN 1949
  • RHP 1991
  • Country
  • STVN Italy
  • RHP United States
  • Employees
  • STVN N/A
  • RHP N/A
  • Industry
  • STVN Containers/Packaging
  • RHP Real Estate Investment Trusts
  • Sector
  • STVN Consumer Discretionary
  • RHP Real Estate
  • Exchange
  • STVN Nasdaq
  • RHP Nasdaq
  • Market Cap
  • STVN 6.6B
  • RHP 6.1B
  • IPO Year
  • STVN 2021
  • RHP 1991
  • Fundamental
  • Price
  • STVN $24.59
  • RHP $103.14
  • Analyst Decision
  • STVN Buy
  • RHP Buy
  • Analyst Count
  • STVN 6
  • RHP 8
  • Target Price
  • STVN $25.08
  • RHP $114.13
  • AVG Volume (30 Days)
  • STVN 337.6K
  • RHP 690.2K
  • Earning Date
  • STVN 08-05-2025
  • RHP 08-04-2025
  • Dividend Yield
  • STVN 0.26%
  • RHP 4.46%
  • EPS Growth
  • STVN N/A
  • RHP N/A
  • EPS
  • STVN 0.50
  • RHP 4.70
  • Revenue
  • STVN $1,215,562,040.00
  • RHP $2,398,388,000.00
  • Revenue This Year
  • STVN $8.69
  • RHP $5.92
  • Revenue Next Year
  • STVN $10.67
  • RHP $8.11
  • P/E Ratio
  • STVN $49.56
  • RHP $21.94
  • Revenue Growth
  • STVN 3.81
  • RHP 9.48
  • 52 Week Low
  • STVN $17.12
  • RHP $76.27
  • 52 Week High
  • STVN $25.88
  • RHP $121.77
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.81
  • RHP 62.46
  • Support Level
  • STVN $24.06
  • RHP $97.19
  • Resistance Level
  • STVN $25.36
  • RHP $101.82
  • Average True Range (ATR)
  • STVN 1.10
  • RHP 2.53
  • MACD
  • STVN 0.01
  • RHP 0.31
  • Stochastic Oscillator
  • STVN 67.06
  • RHP 86.91

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About RHP Ryman Hospitality Properties Inc. (REIT)

Ryman Hospitality Properties Inc is a lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. Its core holdings are Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention Center. The company has three business segments: Hospitality, which includes Gaylord Hotels properties, the Inn at Opryland, and the AC Hotel, Entertainment which includes the entertainment and media assets comprising OEG, and Corporate and Other, which includes corporate expenses. It derives the vast majority of its revenue from its Hospitality segment.

Share on Social Networks: